Beate Bittner

2.2k total citations · 1 hit paper
46 papers, 1.8k citations indexed

About

Beate Bittner is a scholar working on Oncology, Pharmaceutical Science and Pathology and Forensic Medicine. According to data from OpenAlex, Beate Bittner has authored 46 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Pharmaceutical Science and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Beate Bittner's work include Drug Transport and Resistance Mechanisms (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Advanced Drug Delivery Systems (6 papers). Beate Bittner is often cited by papers focused on Drug Transport and Resistance Mechanisms (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Advanced Drug Delivery Systems (6 papers). Beate Bittner collaborates with scholars based in Switzerland, Germany and France. Beate Bittner's co-authors include Johannes Schmidt, Thomas Kissel, W. Richter, Christine McIntyre, Isabelle Walter, Karsten Mäder, Hans Koll, Gerhard Winter, Jörg Huwyler and Florence Hourcade‐Potelleret and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Beate Bittner

44 papers receiving 1.7k citations

Hit Papers

Subcutaneous Administration of Biotherapeutics: An Overvi... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
    2018 304 citations Beate Bittner, W. Richter et al. BioDrugs profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Beate Bittner Switzerland 22 523 398 383 316 262 46 1.8k
Jochem Alsenz Switzerland 29 623 1.2× 731 1.8× 458 1.2× 351 1.1× 127 0.5× 52 2.7k
Steve Weitman United States 23 362 0.7× 1.2k 3.1× 538 1.4× 81 0.3× 322 1.2× 36 2.5k
Chang‐Yao Hsieh Taiwan 30 265 0.5× 1.4k 3.6× 698 1.8× 83 0.3× 320 1.2× 87 3.9k
Taher Nassar Israel 27 415 0.8× 508 1.3× 205 0.5× 64 0.2× 264 1.0× 51 1.9k
Adam W. G. Alani United States 26 537 1.0× 716 1.8× 266 0.7× 144 0.5× 790 3.0× 53 2.3k
Mafalda Videira Portugal 23 336 0.6× 736 1.8× 388 1.0× 122 0.4× 342 1.3× 46 1.7k
Peter Edman Sweden 23 713 1.4× 349 0.9× 75 0.2× 101 0.3× 240 0.9× 60 1.6k
June‐Wha Rhee United States 21 230 0.4× 1.0k 2.6× 250 0.7× 124 0.4× 824 3.1× 56 2.6k
Shen Gao China 36 588 1.1× 1.8k 4.5× 354 0.9× 138 0.4× 630 2.4× 142 3.7k
B. Parodi Italy 17 453 0.9× 378 0.9× 148 0.4× 61 0.2× 207 0.8× 74 1.4k

Countries citing papers authored by Beate Bittner

Since Specialization
Citations

This map shows the geographic impact of Beate Bittner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beate Bittner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beate Bittner more than expected).

Fields of papers citing papers by Beate Bittner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beate Bittner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beate Bittner. The network helps show where Beate Bittner may publish in the future.

Co-authorship network of co-authors of Beate Bittner

This figure shows the co-authorship network connecting the top 25 collaborators of Beate Bittner. A scholar is included among the top collaborators of Beate Bittner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beate Bittner. Beate Bittner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bittner, Beate, Javier Muñoz, Sabine Frank, et al.. (2025). Clinical Qualification of Subcutaneous Injection Devices for Monoclonal Antibodies. BioDrugs. 40(1). 5–21.
2.
Bruin, Gerard, et al.. (2025). An industry perspective on clinical development and regulatory strategies for subcutaneously administered high-dose biologics. Journal of Controlled Release. 386. 114156–114156. 1 indexed citations
3.
Bittner, Beate & Johannes Schmidt. (2023). Advancing Subcutaneous Dosing Regimens for Biotherapeutics: Clinical Strategies for Expedited Market Access. BioDrugs. 38(1). 23–46. 13 indexed citations
4.
Bittner, Beate. (2023). Customer-centric product presentations for monoclonal antibodies. SHILAP Revista de lepidopterología. 9(1). 3–3. 4 indexed citations
5.
Kang, David W., Beate Bittner, Barry J. Sugarman, Monica L. Zepeda, & Marie A. Printz. (2021). Dispersive effects and focused biodistribution of recombinant human hyaluronidase PH20: A locally acting and transiently active permeation enhancer. PLoS ONE. 16(7). e0254765–e0254765. 9 indexed citations
6.
Bittner, Beate, W. Richter, & Johannes Schmidt. (2018). Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities. BioDrugs. 32(5). 425–440. 304 indexed citations breakdown →
7.
Morcos, Peter N., Xiaoping Zhang, Christine McIntyre, et al.. (2013). Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20. International Journal of Clinical Pharmacology and Therapeutics. 51(7). 537–548. 19 indexed citations
8.
Bittner, Beate, Keqi Tang, Wantanee Phuapradit, et al.. (2012). 賦形剤N-[8-(2-ヒドロキシベンゾイル)アミノ]カプリル酸ナトリウム含有イバンドロナートについて新規経口製剤選択のための第I相臨床試験. Pharmazie. 67(3). 233–241. 10 indexed citations
9.
Boess, Franziska, et al.. (2004). In vitro investigation on the impact of Solutol HS 15 on the uptake of colchicine into rat hepatocytes. International Journal of Pharmaceutics. 279(1-2). 27–31. 14 indexed citations
10.
Huwyler, Jörg, et al.. (2004). In vitro investigation on the impact of the surface‐active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam. Biopharmaceutics & Drug Disposition. 25(1). 37–49. 70 indexed citations
11.
Bittner, Beate, et al.. (2003). Impact of Solutol HS 15 on the pharmacokinetic behavior of midazolam upon intravenous administration to male Wistar rats. European Journal of Pharmaceutics and Biopharmaceutics. 56(1). 143–146. 16 indexed citations
12.
Bittner, Beate, et al.. (2003). Impact of solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats. Biopharmaceutics & Drug Disposition. 24(4). 173–181. 29 indexed citations
13.
Bittner, Beate, et al.. (2002). Formulations and related activities for the oral administration of poorly water-soluble compounds in early discovery animal studies: An overview of frequently applied approaches. Part 1. 64(8). 800–807. 21 indexed citations
14.
Huwyler, Jörg, et al.. (2002). Improved oral bioavailability of cyclosporin A in male Wistar rats. International Journal of Pharmaceutics. 245(1-2). 143–151. 31 indexed citations
15.
16.
Schleimer, Michael, et al.. (2000). Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450. International Journal of Pharmaceutics. 211(1-2). 89–92. 84 indexed citations
17.
18.
19.
Bittner, Beate, Michael M. Morlock, Hans Koll, Gerhard Winter, & Thomas Kissel. (1998). Recombinant human erythropoietin (rhEPO) loaded poly(lactide-co-glycolide) microspheres: influence of the encapsulation technique and polymer purity on microsphere characteristics. European Journal of Pharmaceutics and Biopharmaceutics. 45(3). 295–305. 94 indexed citations
20.
Bittner, Beate, et al.. (1998). Bovine serum albumin loaded poly(lactide-co-glycolide) microsphe: the influence of polymer purity on particle characteristics. Journal of Microencapsulation. 15(4). 495–514. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jochem Alsenz Breakdown of academic impact, for papers by Steve Weitman Breakdown of academic impact, for papers by Chang‐Yao Hsieh Breakdown of academic impact, for papers by Taher Nassar Breakdown of academic impact, for papers by Adam W. G. Alani Breakdown of academic impact, for papers by Mafalda Videira Breakdown of academic impact, for papers by Peter Edman Breakdown of academic impact, for papers by June‐Wha Rhee Breakdown of academic impact, for papers by Shen Gao Breakdown of academic impact, for papers by B. Parodi
Rankless by CCL
2026